Announcement on Providing Guarantee for Controlled Subsidiary
Filed with SSE · · 6 pages · Chinese
Summary by 6ix AI
Shandong Buchang Pharmaceuticals Co., Ltd. has announced its provision of a guarantee for its controlled subsidiary, Shanghai He Pu Medical Technology Co., Ltd., to secure a loan agreement with a bank. The guarantee amount is significant and is part of a broader financing strategy approved by the company's board. The board believes this guarantee is necessary for the subsidiary's operational needs and will positively impact the company's development. As of the announcement date, the total amount of guarantees provided by the company and its subsidiaries is substantial, with no overdue guarantees reported.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Shandong Buchang Pharmaceuticals Co., Ltd. on 6ix
Earlier from Shandong Buchang Pharmaceuticals
- (603858)"Shandong Buchang Pharmaceuticals Co., Ltd."Announcement on Proposed Capital Increase in Controlled Subsidiary
- (603858)"Shandong Buchang Pharmaceuticals Co., Ltd."Announcement on Change of Legal Representative of Controlled Subsidiary
- Announcement on Resolutions of the 56th Meeting of the 5th Board of Directors
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on Completion of Industrial and Commercial Registration Change by Controlled Subsidiary
Later from Shandong Buchang Pharmaceuticals
- Announcement on Capital Increase and Share Expansion of Controlled Subsidiary for Introduction of External Investors, the Company's Waiver of Preemptive Subscription Rights, and Related Party Transactions
- (603858)"Shandong Buchang Pharmaceuticals Co., Ltd."Announcement on Cooperative Investment with Private Fund
- (603858)"Shandong Buchang Pharmaceuticals Co., Ltd."Announcement on Proposed External Investment by Controlled Subsidiary for Establishment of Wholly-owned Subsidiary
- (603858)"Shandong Buchang Pharmaceuticals Co., Ltd."Announcement on Resolutions of the 57th Meeting of the 5th Board of Directors
- (603858)"Shandong Buchang Pharmaceuticals Co., Ltd."Announcement on Signing of Technology Transfer Contract by Wholly-owned Subsidiary
Follow Shandong Buchang Pharmaceuticals into a list and get an email when it puts out news.
Follow Shandong Buchang Pharmaceuticals